| AZN Snapshot | |
|---|---|
| AstraZeneca PLC discovers, develops, manufactures and markets prescription drugs in the areas of oncology, cardiovascular, renal and metabolism, respiratory, infections, neuroscience and gastroenterology worldwide. The company is headquartered in Cambridge, the United Kingdom. | |
| VALUATION DATA | |
| Market Capitalization | $220,751,315,000 | Price to Sales | 1.00 |
| Earnings per Share | $1.9100 |
| PE Ratio | 37.28 |
| PRICE DATA | |
| Most Recent Close | $75.1700 |
| 52 Week High | $4.665 |
| 52 Week Low | $5.46 |
| 50-Day Moving Average | $5.2 |
| 200-Day Moving Average | $17.74 |
| All data are from Alpha Vantage as of today. For more infomation on AZN see Stock Dividend, Valuation, Price and Financial Data for Investors | |
Custom Search